What is NDC 71335-3145?

71335-3145 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, coated, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anastrozole?

38 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anastrozole NDC 71335-3145 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-3145Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-3145Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-3145-0	7133531450071335314500	28 TABLET, COATED in 1 BOTTLE (71335-3145-0)Marketed from Jun 18, 2026
71335-3145-1	7133531450171335314501	30 TABLET, COATED in 1 BOTTLE (71335-3145-1)Marketed from Jun 18, 2026
71335-3145-2	7133531450271335314502	20 TABLET, COATED in 1 BOTTLE (71335-3145-2)Marketed from Jun 18, 2026
71335-3145-3	7133531450371335314503	90 TABLET, COATED in 1 BOTTLE (71335-3145-3)Marketed from Jun 18, 2026
71335-3145-4	7133531450471335314504	4 TABLET, COATED in 1 BOTTLE (71335-3145-4)Marketed from Jun 18, 2026
71335-3145-5	7133531450571335314505	6 TABLET, COATED in 1 BOTTLE (71335-3145-5)Marketed from Jun 18, 2026
71335-3145-6	7133531450671335314506	10 TABLET, COATED in 1 BOTTLE (71335-3145-6)Marketed from Jun 18, 2026
71335-3145-7	7133531450771335314507	40 TABLET, COATED in 1 BOTTLE (71335-3145-7)Marketed from Jun 18, 2026
71335-3145-8	7133531450871335314508	12 TABLET, COATED in 1 BOTTLE (71335-3145-8)Marketed from Jun 18, 2026
71335-3145-9	7133531450971335314509	14 TABLET, COATED in 1 BOTTLE (71335-3145-9)Marketed from Jun 18, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anastrozole
Generic name (nonproprietary): anastrozole
Active ingredients: Anastrozole — 1 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078921
Marketing start: Jun 27, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Aromatase Inhibitors (Mechanism)
Identifiers: Product ID 71335-3145_51d68c25-5310-4c4d-8c95-83e3c17815f3SPL ID 51d68c25-5310-4c4d-8c95-83e3c17815f3SPL set ID f5b53383-0366-4ae2-9aa4-88b56c0bbd07RxCUI 199224UNII 2Z07MYW1AZ
Pharmacologic class: Aromatase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335314500 followed by a unit qualifier and the quantity

Package 71335-3145-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 18, 2026.

Indications (excerpt from the label)

Anastrozole is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer ( 1.1 ) First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1.2 ) Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole ( 1.3 ) 1.1 Adjuvant Treatment Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive ea…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-3145

What is NDC 71335-3145?: 71335-3145 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, coated, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anastrozole.
What is the active ingredient?: Anastrozole.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anastrozole?: 38 other product NDCs are listed under this name. See all Anastrozole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Anastrozole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-682	72189-0682-30
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-575	72789-0575-1572789-0575-30
Anastrozoleanastrozole tablets	Anastrozole 1 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	24979-725	24979-0725-0624979-0725-07
Anastrozole	Anastrozole 1 mg/1	TabletOral	AvKARE	42291-016	42291-0016-3042291-0016-90
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-415	72189-0415-30
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-236	59651-0236-3059651-0236-90
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	AvKARE	42291-085	42291-0085-3042291-0085-90
Anastrozole	Anastrozole 1 mg/1	TabletOral	AvPAK	50268-075	50268-0075-15
Anastrozoleanastrozole tablets	Anastrozole 1 mg/1	TabletOral	Avet Pharmaceuticals Inc	23155-857	23155-0857-0323155-0857-0523155-0857-09
Anastrozole	Anastrozole 1 mg/1	TabletOral	Chartwell RX, LLC	62135-490	62135-0490-3062135-0490-90

All 39 Anastrozole NDCs

Other NDCs under ANDA 078921

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078921
Product	Strength	Form · route	Labeler	Product NDC
Anastrozole	Anastrozole 1 mg/1	Tablet, CoatedOral	American Health Packaging	60687-112
Anastrozole	Anastrozole 1 mg/1	Tablet, CoatedOral	Zydus Lifesciences Limited	65841-743
Anastrozole	Anastrozole 1 mg/1	Tablet, CoatedOral	BluePoint Laboratories	68001-155
Anastrozole	Anastrozole 1 mg/1	Tablet, CoatedOral	Zydus Pharmaceuticals USA Inc.	68382-209
Anastrozole	Anastrozole 1 mg/1	Tablet, CoatedOral	PD-Rx Pharmaceuticals, Inc.	72789-342